当前位置:武汉原生原代生物医药科技有限公司>>成功案例
当前位置:武汉原生原代生物医药科技有限公司>>成功案例
当前位置:武汉原生原代生物医药科技有限公司>>成功案例
贺首都医科大学附属北京佑安医院等单位应用PriCells产品/技术服务发表文章
Comparison of the regulation of β-catenin signaling by type I, type II and type III interferons in hepatocellularcarcinoma cells.
PLoS One. 2012;7(10):e47040. doi: 10.1371/journal.pone.0047040. Epub 2012 Oct 4.
Wei Li1, Xiaojie Huang1, Hongfei Tong2, Yuxuan Wang4, Tong Zhang1, Wen Wang1, Lili Dai1,Tongzeng Li1, Shengzhang Lin3*, Hao Wu1*
1Department of Infectious Diseases, Beijing You’an Hospital, Capital Medical University, Beijing, China,
2Department of General Surgery, Second Affiliated Hospital,Wenzhou Medical College, Wenzhou, Zhejiang, China,
3Department of Hepato-biliary-pancreatic Surgery, First Affiliated Hospital, Zhejiang University School of Medicine,Hangzhou, Zhejiang, China,
4Materials Science and Engineering Program, State University of New York at Binghamton, Binghamton, New York, United States of America
The hepatocellular carcinoma cell lines, PriCells, Wuhan, China
请输入账号
请输入密码
请输验证码
以上信息由企业自行提供,信息内容的真实性、准确性和合法性由相关企业负责,化工仪器网对此不承担任何保证责任。
温馨提示:为规避购买风险,建议您在购买产品前务必确认供应商资质及产品质量。